Emerging pharmacological strategies for the treatment of fibromyalgia

doi:10.5497/wjp.v6.i1.1

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (14987)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

695

WORD

448

HTML

8216

Tables (1-3)

254

Sum=9613

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

1399

Download

1820

Sum=3219

Publishing Process of This Article

Item

Count

Browse

1030

Download

1125

Sum=2155

Mar 9, 2017 (publication date) through Nov 19, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Pharmacology

ISSN

2220-3192

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Pharmacology. Mar 9, 2017; 6(1): 1-10
Published online Mar 9, 2017. doi: 10.5497/wjp.v6.i1.1

Table 1 Currently recommended drugs for the management of fibromyalgia[9,30,31]

Drug	Mechanism of action	Symptom improved
Amitriptyline	Tricyclic antidepressant	Pain, sleep, fatigue
Cyclobenzaprine	Tricyclic antidepressant	Sleep
Duloxetine	Serotonin-noradrenaline reuptake inhibitor	Pain, sleep
Milnacipran	Serotonin-noradrenaline reuptake inhibitor	Pain, fatigue
Pregabalin	α2δ ligand	Pain, sleep, fatigue
Tramadol	Weak opioid and serotonin-noradrenaline reuptake inhibitor	Pain

Citation: Lawson K. Emerging pharmacological strategies for the treatment of fibromyalgia. World J Pharmacology 2017; 6(1): 1-10
URL: https://www.wjgnet.com/2220-3192/full/v6/i1/1.htm
DOI: https://dx.doi.org/10.5497/wjp.v6.i1.1